Evidence map›Paper›PMID 31074239›Full record

ArticleJournal of gynecologic oncology2019

Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes.

Hanifi Şahin, Funda Karatas, Gonca Coban, Özlem Özen, Özlem Erdem, Mehmet Anıl Onan, Ali Ayhan

Abstract readMulticenter Study
In one paragraph

Article in Journal of gynecologic oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Uterine smooth muscle tumors with uncertain malignant potential: analysis following fertility-saving procedures.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hanifi ŞahinDepartment of Gynecologic Oncology, Malatya Education and Research Hospital, Malatya, Turkey. hanifi.81_@hotmail.com.ORCID https://orcid.org/0000-0001-8522-9119
Funda KaratasDepartment of Gynecologic Oncology, School of Medicine, Gazi University, Ankara, Turkey.ORCID https://orcid.org/0000-0002-1408-6875
Gonca CobanDepartment of Obstetrics and Gynecology, School of Medicine, Baskent University, Ankara, Turkey.ORCID https://orcid.org/0000-0002-3285-5519
Özlem ÖzenDepartment of Pathology, School of Medicine, Baskent University, Ankara, Turkey.ORCID https://orcid.org/0000-0002-9082-1317
Özlem ErdemDepartment of Pathology, School of Medicine, Gazi University, Ankara, Turkey.ORCID https://orcid.org/0000-0002-5981-4856
Mehmet Anıl OnanDepartment of Gynecologic Oncology, School of Medicine, Gazi University, Ankara, Turkey.ORCID https://orcid.org/0000-0001-7643-1585
Ali AyhanDepartment of Gynecologic Oncology, School of Medicine, Baskent University, Ankara, Turkey.ORCID https://orcid.org/0000-0001-7155-9096

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn this study, we aimed to evaluate the clinicopathological features, obstetric, and oncological outcomes of patients diagnosed with a uterine smooth muscle tumors of uncertain malignant potential (STUMP).

methodsA dual-institutional, database review was carried out to screen patients with STUMP who were treated with upfront surgery between January 2006 and December 2017. Data including age at the time of diagnosis, recurrence rate, disease-free survival, overall survival, and fertility outcomes were retrospectively analyzed.

resultsFifty-seven patients with STUMPs were included in the study. The median age at the time of diagnosis was 42 (range, 16 to 75) years. The median follow-up was 57 (range, 16 to 125) months. Eight patients (14%) had recurrence during follow-up. Recurrent STUMPs were seen in seven patients and leiomyosarcoma after 14 months in one patient. Seven patients with a recurrent STUMP survived, while the remaining patient died. Recurrence rates were similar for women who underwent myomectomy and those who underwent hysterectomy. The presence of uterine localization of tumor (subserosal

conclusionsOur study results suggest that fertility-sparing approaches are feasible in patients with STUMP, although recurrence may be seen.

Indexed as

AdultAgedCase-Control StudiesDisease-Free SurvivalFemaleFertility PreservationHumansHysterectomyLeiomyosarcomaMiddle AgedNeoplasm Recurrence, LocalPregnancyRetrospective StudiesSingle-Blind MethodSmooth Muscle TumorUterine MyomectomyHysterectomyMyomectomyRecurrenceSmooth muscle tumors, uterine

Identifiers

PMID31074239
PMCPMC6543118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.